spacer
spacer
Go to PDB code: 
protein ligands links
Transport protein PDB-id
2qju
    Jmol     Help!  
Contents
Description
Header details
Header records
References
PROCHECK
Protein chain
509 a.a. *
Ligands
BOG ×4
LEU
DSM
Metal ions
_NA ×2
_CL
Waters ×15

* Residue conservation analysis
Tools
Image Generation
AstexViewer™@PDBe
Run PROCHECK
Clefts Calculation
  
PDB id: 2qju
Name: Transport protein
Title: Crystal structure of an nss homolog with bound antidepressant

Structure:
Transporter. Chain: a. Engineered: yes

Source:
Aquifex aeolicus vf5. Organism_taxid: 224324. Strain: vf5. Gene: snf. Expressed in: escherichia coli. Expression_system_taxid: 562.

UniProt:
O67854 (O67854_AQUAE) Pfam  
Seq:
Struc:
Seq: 513 a.a.
Struc: 509 a.a.
Key:    PfamA domain
 Secondary structure  CATH domain

Resolution:
2.90Å

R-factor:
0.199

R-free:
0.220

Authors:
Z.Zhou,N.K.Karpowich,D.N.Wang

Key ref:
Z.Zhou et al. (2007). LeuT-desipramine structure reveals how antidepressants block neurotransmitter reuptake.. Science, 317, 1390-1393. [PubMed id: 17690258] [DOI: 10.1126/science.1147614]

Date:
09-Jul-07

Release date:
21-Aug-07

Related entries:
2a65
Quick_links
RCSB
PDBe
SRS
MMDB
JenaLib
OCA
Proteopedia
CATH
SCOP
FSSP
HSSP
PDBSWS
PDBbind
PQS
ProSAT
Whatcheck
EDS
Procheck
Go to PROCHECK summary
Clefts
Clefts
Surface
RasMol surface
spacer
spacer

 
    Key reference    
 
 
DOI no: 10.1126/science.1147614 Science 317:1390-1393 (2007)
PubMed id: 17690258  
 
 
LeuT-desipramine structure reveals how antidepressants block neurotransmitter reuptake.
Z.Zhou, J.Zhen, N.K.Karpowich, R.M.Goetz, C.J.Law, M.E.Reith, D.N.Wang.
 
  ABSTRACT  
 
Tricyclic antidepressants exert their pharmacological effect-inhibiting the reuptake of serotonin, norepinephrine, and dopamine-by directly blocking neurotransmitter transporters (SERT, NET, and DAT, respectively) in the presynaptic membrane. The drug-binding site and the mechanism of this inhibition are poorly understood. We determined the crystal structure at 2.9 angstroms of the bacterial leucine transporter (LeuT), a homolog of SERT, NET, and DAT, in complex with leucine and the antidepressant desipramine. Desipramine binds at the inner end of the extracellular cavity of the transporter and is held in place by a hairpin loop and by a salt bridge. This binding site is separated from the leucine-binding site by the extracellular gate of the transporter. By directly locking the gate, desipramine prevents conformational changes and blocks substrate transport. Mutagenesis experiments on human SERT and DAT indicate that both the desipramine-binding site and its inhibition mechanism are probably conserved in the human neurotransmitter transporters.
 
  Selected figure(s)  
 
Figure 2.
Fig. 2. Structure of the LeuT-desipramine complex and molecular mechanism of LeuT inhibition by desipramine. (A) Structure shown as ribbon diagram viewed from within the membrane plane. An F[obs] – F[calc] map contoured at 3 is superimposed on the structural model. The EL4 hairpin is colored green, and the rest of the protein pink. The helices TM6 and TM11 are removed for clarity. (B) 2F[obs] – F[calc] map contoured at 1 showing the desipramine-binding site in LeuT, viewed from within the membrane plane. Residues R30, Y108, and F253 form the extracellular gate that separates the leucine substrate from the bound desipramine. (C) Local structural changes of LeuT induced by desipramine binding. The structure with desipramine bound is shown in pink and green, without desipramine binding in cyan and blue. When desipramine binds, the side chain of R30 rotates toward D404 and forms a salt bridge with the latter, and the EL4 hairpin, along with A319 and F320, is pushed toward to the extracellular space. (D) Molecular contacts between LeuT and the bound desipramine molecule. The chemical structure of desipramine is shown together with LeuT residues that are in direct contact with the drug. Residues from the EL4 hairpin are shown in the green box; residues from the rest of the protein are shown in pink boxes.
Figure 3.
Fig. 3. Homology models and electrostatic surface potential of desipramine-binding sites in human SERT, NET, and DAT. (A) Desipramine-binding site in the LeuT-desipamine crystal structure. Homology model and electrostatic surface potential of desipramine-binding site in (B) hSERT, (C) hNET, and(D) hDAT, viewed from within the membrane plane. The equivalent residues of those in LeuT that are in direct contact with desipramine are indicated.
 
  The above figures are reprinted by permission from the AAAs: Science (2007, 317, 1390-1393) copyright 2007.  
  Figures were selected by the author.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
19238460 A.W.Ravna, I.Sylte, and S.G.Dahl (2009).
Structure and localisation of drug binding sites on neurotransmitter transporters.
  J Mol Model, 15, 1155-1164.  
18977735 E.Gouaux (2009).
Review. The molecular logic of sodium-coupled neurotransmitter transporters.
  Philos Trans R Soc Lond B Biol Sci, 364, 149-154.  
19458710 H.Krishnamurthy, C.L.Piscitelli, and E.Gouaux (2009).
Unlocking the molecular secrets of sodium-coupled transporters.
  Nature, 459, 347-355.  
19557250 J.Andersen, A.S.Kristensen, B.Bang-Andersen, and K.Strømgaard (2009).
Recent advances in the understanding of the interaction of antidepressant drugs with serotonin and norepinephrine transporters.
  Chem Commun (Camb), 0, 3677-3692.  
19307590 M.Quick, A.M.Winther, L.Shi, P.Nissen, H.Weinstein, and J.A.Javitch (2009).
Binding of an octylglucoside detergent molecule in the second substrate (S2) site of LeuT establishes an inhibitor-bound conformation.
  Proc Natl Acad Sci U S A, 106, 5563-5568.
PDB codes: 3gjc 3gjd
19430461 Z.Zhou, J.Zhen, N.K.Karpowich, C.J.Law, M.E.Reith, and D.N.Wang (2009).
Antidepressant specificity of serotonin transporter suggested by three LeuT-SSRI structures.
  Nat Struct Mol Biol, 16, 652-657.  
18844672 A.M.Jørgensen, and S.Topiol (2008).
Driving forces for ligand migration in the leucine transporter.
  Chem Biol Drug Des, 72, 265-272.  
18668099 B.I.Kanner (2008).
Structural biology: It's not all in the family.
  Nature, 454, 593-594.  
18357440 B.Wenge, and H.Bönisch (2008).
N-Ethylmaleimide differentially inhibits substrate uptake by and ligand binding to the noradrenaline transporter.
  Naunyn Schmiedebergs Arch Pharmacol, 377, 255-265.  
18446902 H.Zettl, M.Schubert-Zsilavecz, and C.D.Siebert (2008).
[The medicinal chemistry of tricyclic antidepressives. Targets and stereochemistry]
  Pharm Unserer Zeit, 37, 206-213.  
18426798 J.Kniazeff, L.Shi, C.J.Loland, J.A.Javitch, H.Weinstein, and U.Gether (2008).
An intracellular interaction network regulates conformational transitions in the dopamine transporter.
  J Biol Chem, 283, 17691-17701.  
18266934 K.Severinsen, S.Sinning, H.K.Müller, and O.Wiborg (2008).
Characterisation of the zebrafish serotonin transporter functionally links TM10 to the ligand binding site.
  J Neurochem, 105, 1794-1805.  
18024499 L.Celik, B.Schiøtt, and E.Tajkhorshid (2008).
Substrate binding and formation of an occluded state in the leucine transporter.
  Biophys J, 94, 1600-1612.  
18647834 L.R.Forrest, Y.W.Zhang, M.T.Jacobs, J.Gesmonde, L.Xie, B.H.Honig, and G.Rudnick (2008).
Mechanism for alternating access in neurotransmitter transporters.
  Proc Natl Acad Sci U S A, 105, 10338-10343.  
19074341 S.K.Singh, C.L.Piscitelli, A.Yamashita, and E.Gouaux (2008).
A competitive inhibitor traps LeuT in an open-to-out conformation.
  Science, 322, 1655-1661.
PDB codes: 3f3a 3f3c 3f3d 3f3e 3f48 3f4i 3f4j
18568020 T.Beuming, J.Kniazeff, M.L.Bergmann, L.Shi, L.Gracia, K.Raniszewska, A.H.Newman, J.A.Javitch, H.Weinstein, U.Gether, and C.J.Loland (2008).
The binding sites for cocaine and dopamine in the dopamine transporter overlap.
  Nat Neurosci, 11, 780-789.  
18257176 S.Kitayama, and T.Dohi (2007).
[New development in study of neurotransmitter transporters]
  Nippon Yakurigaku Zasshi, 130, 443.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB codes are shown on the right.